We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Nanomaterial Promises Enhanced Detection and Treatment of Breast Cancer

By HospiMedica International staff writers
Posted on 07 Jan 2014
A collaboration of scientists from the United Kingdom, Denmark, Brazil, and Germany are devising new detection and treatment technology for breast cancer patients.

The study’s findings were published December 2013 in the Journal of Alloys and Compounds. Current diagnostic methods such as mammograms can only detect between 65% and 95% of tumors, and developing better ways of detection is of prime urgency. More...
If not detected and treated early enough, breast cancer can spread to other areas of the body, increasing the probability that the disease will become lethal.

The team of scientists has been using the Polaris instrument at the ISIS pulsed neutron and muon source at the Rutherford Appleton Laboratory (Harwell Oxford, UK) to develop a new bio-nanocomposite that they hope will eventually lead to earlier detection, and more successful treatment, of breast cancer. The new substance exploits the fact that cancer cells attract a molecule called hydroxyapatite, which is a component of bones. The researchers are developing magnetic nanoparticles coated with a biocompatible polymer that includes hydroxyapatite nanocrystals. When administered into the body, these nanoparticles should travel right to cancer cells, and once they do, they make it much easier to detect the tumor on an MRI scan.

Not only do the nanoparticles help to identify tumors, but they may also help to block the metastasis to other areas of the body, as hydroxyapatite is known to suppress that facet of tumor activity.

The next phase of study is to incorporate antitumor agents into the nanoparticles. The magnetic nature of the nanoparticles means that they can be directed to the site of the tumor by using magnets outside of the body. If antitumor drugs can be added to the nanoparticles, then they can be used to deliver the treatment directly to the tumor, optimizing the effectiveness of the treatment and reducing the risk of harmful side effects--imagine a fleet of tiny drones, delivering anticancer weapons right where they are needed.

This research is at a very early stage, and far more study is required, according to the scientists, before it can be developed into a treatment option.

ISIS generates beams of neutrons and muons that allow scientists to study materials at the atomic level using a suite of instruments, frequently described as super-microscopes. It supports a national and international community of more than 2,000 scientists who use neutrons and muons for research in physics, chemistry, materials science, geology, engineering, and biology.

Related Links:

ISIS



Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Glucose Meter
StatStrip®
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.